LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics


LeMaitre Vascular, Inc. (LMAT): $43.87

-0.46 (-1.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LMAT POWR Grades


  • LMAT scores best on the Stability dimension, with a Stability rank ahead of 82.77% of US stocks.
  • The strongest trend for LMAT is in Momentum, which has been heading down over the past 179 days.
  • LMAT ranks lowest in Momentum; there it ranks in the 16th percentile.

LMAT Stock Summary

  • LMAT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 137.94 -- higher than 82.83% of US-listed equities with positive expected earnings growth.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.24 for Lemaitre Vascular Inc; that's greater than it is for only 14.67% of US stocks.
  • With a year-over-year growth in debt of -70.91%, Lemaitre Vascular Inc's debt growth rate surpasses only 3.97% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Lemaitre Vascular Inc, a group of peers worth examining would be BIOL, RWLK, FCEL, GMED, and CSPI.
  • Visit LMAT's SEC page to see the company's official filings. To visit the company's web site, go to www.lemaitre.com.

LMAT Valuation Summary

  • LMAT's price/sales ratio is 8.1; this is 28.63% lower than that of the median Healthcare stock.
  • LMAT's price/sales ratio has moved up 5.2 over the prior 181 months.
  • Over the past 181 months, LMAT's price/earnings ratio has gone up 256.6.

Below are key valuation metrics over time for LMAT.

Stock Date P/S P/B P/E EV/EBIT
LMAT 2021-08-31 8.1 6.6 42.6 32.3
LMAT 2021-08-30 8.2 6.6 42.7 32.3
LMAT 2021-08-27 8.1 6.6 42.4 32.1
LMAT 2021-08-26 7.8 6.3 40.9 31.0
LMAT 2021-08-25 7.9 6.4 41.1 31.1
LMAT 2021-08-24 7.9 6.4 41.5 31.4

LMAT Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at 17.23%.
  • Its year over year net income to common stockholders growth rate is now at 36.26%.
  • The 2 year net cashflow from operations growth rate now stands at -35.44%.
LMAT's revenue has moved up $46,371,000 over the prior 34 months.

The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 154.424 35.102 26.907
2021-09-30 152.469 44.198 27.765
2021-06-30 150.517 44.235 28.774
2021-03-31 134.698 39.685 23.975
2020-12-31 129.366 34.8 21.22
2020-09-30 121.988 26.242 18.8

LMAT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LMAT has a Quality Grade of B, ranking ahead of 84.43% of graded US stocks.
  • LMAT's asset turnover comes in at 0.589 -- ranking 73rd of 186 Medical Equipment stocks.
  • ISRG, SYK, and KIDS are the stocks whose asset turnover ratios are most correlated with LMAT.

The table below shows LMAT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.589 0.655 0.287
2021-06-30 0.597 0.649 0.299
2021-03-31 0.530 0.653 0.241
2020-12-31 0.542 0.654 0.220
2020-09-30 0.548 0.657 0.196
2020-06-30 0.574 0.677 0.177

LMAT Price Target

For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $66.14 Average Broker Recommendation 1.5 (Moderate Buy)

LMAT Stock Price Chart Interactive Chart >

Price chart for LMAT

LMAT Price/Volume Stats

Current price $43.87 52-week high $64.50
Prev. close $44.33 52-week low $38.32
Day low $43.19 Volume 103,900
Day high $44.61 Avg. volume 125,636
50-day MA $44.80 Dividend yield 1.13%
200-day MA $49.09 Market Cap 963.03M

LeMaitre Vascular, Inc. (LMAT) Company Bio


LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.


LMAT Latest News Stream


Event/Time News Detail
Loading, please wait...

LMAT Latest Social Stream


Loading social stream, please wait...

View Full LMAT Social Stream

Latest LMAT News From Around the Web

Below are the latest news stories about Lemaitre Vascular Inc that investors may wish to consider to help them evaluate LMAT as an investment opportunity.

LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q4 2021 Results - Earnings Call Transcript

LeMaitre Vascular, Inc. (LMAT) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Company Participants JJ Pellegrino – Chief Financial Officer George LeMaitre – Chairman and Chief Executive Officer Dave Roberts – President Conference Call Participants Brooks O’Neil – Lake Street Scott Henry – Roth Capital Zachary Weiner...

SA Transcripts on Seeking Alpha | February 25, 2022

LeMaitre Vascular (LMAT) Misses Q4 Earnings and Revenue Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -9.68% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

LeMaitre Q4 2021 Financial Results

BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly dividend (+14%) and provided guidance. Q4 2021 Financial Results Sales of $39.5mm, +5% (+6% organic) vs. Q4 2020Op. income of $8.3mm, -13%Op. margin of 21%Net income of $6.2mm, -12%Earnings of $0.28 per diluted share, -18%Cash and investments +$2.9mm to $70.0mm Q4 2021 sales were driven by bovine gra

Yahoo | February 24, 2022

NuVasive (NUVA) Q4 Earnings Lag Estimates

NuVasive (NUVA) delivered earnings and revenue surprises of -14.89% and 1.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 17, 2022

Read More 'LMAT' Stories Here

LMAT Price Returns

1-mo -3.96%
3-mo -3.84%
6-mo -9.54%
1-year -11.31%
3-year 70.16%
5-year 52.58%
YTD -12.18%
2021 25.10%
2020 14.09%
2019 53.77%
2018 -25.13%
2017 26.58%

LMAT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LMAT Dividend History

Continue Researching LMAT

Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:

Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6404 seconds.